ARNI
Price:
$0.0001
Market Cap:
$4.93K
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various ant...[Read more]
Industry
Biotechnology
IPO Date
2008-06-11
Stock Exchange
OTC
Ticker
ARNI
According to Arno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 250.44%. This represents a change of 304.56% compared to the average of 61.90% of the last 4 quarters.
The mean historical ROE of Arno Therapeutics, Inc. over the last ten years is -206.16%. The current 250.44% ROE has changed -221.48% with respect to the historical average. Over the past ten years (40 quarters), ARNI's ROE was at its highest in in the September 2007 quarter at 262.91%. The ROE was at its lowest in in the December 2014 quarter at -774.87%.
Average
-206.16%
Median
-105.97%
Minimum
-1319.56%
Maximum
451.95%
Discovering the peaks and valleys of Arno Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.17%
Maximum Annual ROE = 451.95%
Minimum Annual Increase = -1001.54%
Minimum Annual ROE = -1319.56%
| Year | ROE | Change |
|---|---|---|
| 2015 | 133.77% | -110.14% |
| 2014 | -1319.56% | -391.97% |
| 2013 | 451.95% | 167.17% |
| 2012 | 169.16% | -127.97% |
| 2011 | -604.88% | 1.17% |
| 2010 | -47.69% | -89.17% |
| 2009 | -440.22% | 168.02% |
| 2008 | -164.24% | -39.12% |
| 2007 | -269.79% | -1001.54% |
| 2006 | 29.93% | -32.43% |
The current ROE of Arno Therapeutics, Inc. (ARNI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-244.61%
5-year avg
-233.91%
10-year avg
-206.16%
Arno Therapeutics, Inc.’s ROE is greater than Panacos Pharmaceuticals, Inc. (-85.57%), greater than Calithera Biosciences, Inc. (-131.13%), greater than TetraLogic Pharmaceuticals Corporation (-408.63%), less than Innovation1 Biotech Inc. (2.07%), greater than Better Therapeutics, Inc. (-221.99%), greater than Oncology Pharma Inc. (-19427.83%), less than Baudax Bio, Inc. (1.07%), greater than Kaleido Biosciences, Inc. (-580.57%), greater than Ampio Pharmaceuticals, Inc. (-113.96%), less than Tengion, Inc. (188.30%),
| Company | ROE | Market cap |
|---|---|---|
| -85.57% | $5.37K | |
| -131.13% | $975.00 | |
| -408.63% | $2.45K | |
| 2.07% | $4.49K | |
| -221.99% | $5.45K | |
| -19427.83% | $109.55K | |
| 1.07% | $436.00 | |
| -580.57% | $213.11K | |
| -113.96% | $5.90K | |
| 188.30% | $4.03K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Arno Therapeutics, Inc.'s ROE?
How is the ROE calculated for Arno Therapeutics, Inc. (ARNI)?
What is the highest ROE for Arno Therapeutics, Inc. (ARNI)?
What is the 3-year average ROE for Arno Therapeutics, Inc. (ARNI)?
What is the 5-year average ROE for Arno Therapeutics, Inc. (ARNI)?
How does the current ROE for Arno Therapeutics, Inc. (ARNI) compare to its historical average?